Over the past ten years, Janssen has advanced ten new oncology drugs through regulatory approval, including several first-in-class medicines (Fig. 1). Among these are the first fully human bispecific antibody for lung cancer, the first Bruton’s tyrosine kinase (BTK) inhibitor for B cell malig...
Janssen’s pipeline includes investigational vaccines to prevent some of the world’s deadliest infectious diseases, including HIV, respiratory syncytial virus (RSV), influenza, Ebola and Zika. In addition to supporting the development and launch of these vaccines, the new facility can also support g...
Targeting disease with precision medicine We’re taking on the world’s most challenging diseases with treatments specifically tailored to the patients we serve. See this in action for lung cancer Our impact 180M+ Patients treated globally with one of our medicines ...
Aicher et al., “Kappa Opioid Receptor (KOR) and GAD67 Immunoreactivity Are Found in OFF and Neutral Cells in the Rostral Ventromedial Medulla.”, J. Neurophysiol, 2006, vol. 96, pp. 3465-3473, Caplus an 2006:440111. Amgen-Investors-Pipeline; http://www.amgen.com/investors/pipe—AMG221...